Introduction
Aurintricarboxylic acid (ATA) is a heterogeneous mixture of polymers formed upon treatment of salicylic acid with formaldehyde, sulphuric acid, and sodium nitrite (Caro 1892; Gonzalez et el., 1979; Cushman and Kanamathareddy, 1990; Cushman et al., 1991b) . Recent interest in ATA has been stimulated by its ability to selectively inhibit the replication of human immunodeficiency virus .type 1 (HIV-1) and type 2 (HIV-2) in a variety of lymphocyte cell culture systems Baba et el., 1988) . By flow cytometric analysis, it has been demonstrated that ATA inhibits (i) the binding of anti-HIV glycoprotein (gp) 120 monoclonal antibody (mAb) to HIV-1 gp120 and (ii) the binding of OKT4A1Leu3a mAb to the cellular CD4 receptor resulting in an inhibition of the initial interaction [i.e., attachment of HIV-1 to its host cells (Schols et al., 1989a (Schols et al., , 1990 ]. To obtain insight in the structural specificity of the antiviral action of ATA, a variety of related polymers have been developed and evaluated for their activity against HIV and human cytomegalovirus (HCMV) (Cushman et al., 1995) . The present study was aimed at determining the spectrum of antiviral activity of these polymers and their mechanism of antiviral action. The ATA-derived polymers proved particularly inhibitory to the replication of HIV-1, HCMV and human herpesvirus type 6 (HHV-6). Using flow cytometric analysis, we have demonstrated that this novel series of ATA polymers interacts with both the HIV-1 gp120 glycoprotein and the cellular CD4 receptor, and consequently inhibits virus adsorption to CD4+cells.
Results

Antiviral activity of the A TA related polymers
When the ATA related polymer analogues were examined for their inhibitory effects on the replication of DNA viruses, they proved fairly inhibitory to the herpesviruses HSV-1, HSV-2, and TK-HSV-1, with their EC 5 0 ranging from 7/1g ml-1 for polymers 1 and 2 to 70 /1g mr:' for polymer 7 as compared to 2-20 /1g mr' for ATA and dextran sulphate (OS) . Their minimal cytotoxic concentrations were 100 /1g ml-1 or more (data not shown). Polymer 3 was biologically inactive, while the highest activity was noted with polymers 1 and 2. The ATA related polymers were most active against HHV-6type A (strain GS) and HCMV (strain Davis) ICso (l-1g rnl")" . a ATA, ATA analogues and cosalane were tested as their ammonium salts b 50% inhibitory concentration, based on the inhibition of cytopathic effect of HCMV in HEL cells; HHV-6 in H8B-2 cells; and H8V-1, HSV-2, TK-H8V-1 and Vaccinia virus in E 68M cells. Virus was added in the presence of the compounds and the cells were further incubated until CPE was scored. All data represent mean values for at least two experiments.
with an EC so ranging from 1.4 I1g rnr' (polymer 1) to 16.5 I1g rnr ' (polymer 8) for HHV-6 and from 1.1 I1g mr" (polymers 1 and 2) to 26.5119 mr' (polymer 7) for HCMV (Table   1) . When tested under the same conditions, ATA showed an EC so of 2.1 I1g mr" against HHV-6 and 0.8 I1g mr" against HCMV, while OS had an EC so of 1.5 I1g rnr" against HHV-6 and of 1.1 I1g mr' against HCMV.
The ATA related polymers were also evaluated for their inhibitory effects on the cytopathic effect of a wide array of RNA viruses. As shown in Table 2 , several of the new polymers were 5-to 40-fold less active against Junin virus and Tacaribe virus, as compared to ATA (EC so : 1.3 I1g mr") and OS (EC so : 10 I1g rnl"). Some moderate activity (EC so ranging from 70 I1g mr' for polymer 1 to 150 I1g mr' for polymers 3, 6 and 7) was noted against Sindbis virus and VSV. Also, the polymers were only slightly active against Punta Toro virus and Yellow Fever virus, with EC so values ranging from approximately 35 119 rnr' for polymer 1 and cosalane to approximately 175119 mr' for polymer 8. Again, no antiviral activity was observed for polymer 3. None of the compounds proved inhibitory to Semliki Forest virus, parainfluenza-3 virus and to non-ICso (l-1g rnr')" enveloped RNA viruses (l.e.: polio, Coxsackie and reovirus) at concentrations up to 400 119 mr-1 (data not shown). As shown in Table 2 , the polymers were most active againstthe replication of HIV-1, their EC so ranging from 0.5 119 rnr" (polymer 2) to 4.4119 mr' (polymer 7) as compared to ATA (EC so : 0.3119 mr') and DS (EC so : 0.03 119 mr"). Overall, polymers 1; 2 and cosalane emerged as the most potent of the new substances taken up in this study, their antiviral spectrum being essentially identical to that of ATA.
Mechanism of antiviral action of the ATA-related polymers against HCMV
To delineate the mechanism of anti-HCMV action of the ATA polymers, the compounds were evaluated for their ability to inhibit the binding of radiolabelled HCMV particles to HEL cells. As shown in Table 1 and Table 3 , those polymer analogues that displayed the highest activity against HCMV-induced cytopathic effect (Table 1) , also proved most inhibitory to the binding of radiolabelled HCMV particles to HEL cells (Table 3) ; for example, at 25 119 mr' polymer 1 (EC so : 1.1 119 rnr") inhibited the binding of HCMV by 84.4%, whereas polymer 8, which was less active in the HCMV cytopathicity assay (EC so : 13.4 119 mr'), inhibited the binding by only 71%. Also, the EC so values for inhibition of binding of radiolabelled HCMV particles to HEL cells correlated well (r = 0.802) with the EC so values of the compounds in the HCMV cytopathicity assay (Table 1) , except for cosalane (with an EC so for inhibition of binding of more than 100 119 mr' in contrast to an EC so of inhibition of viral cytopathic effect of 1.2 119 mr'),
Nevertheless, these findings suggest that the activity of the ATA polymers against HCMV is due to inhibition of virus adsorption to the host cells.
Inhibitory effects of the ATA-related polymers on HIV adsorption
It has been previously demonstrated by a flow cytometric method that ATA blocks HIV-1 binding to MT-4 cells (Schols et al., 1989b; Cushman et aI, 1991a Cushman et aI, , 1991b . This finding apparently extends to the new ATA analogues, which were also found to suppress HIV-1 adsorption to MT-4 cells (Table 4 ). At 25 119 mr', polymers 1, 4 and 2 achieved a marked inhibitory effect on virus binding (II va: 0.66, 0.65 and 0.55 for polymers 1, 4 and 2, respectively), followed by polymers 5 (II va: 0.48) and 6 (II va: 0.41).
When tested under the same conditions, ATA and DS showed llvs values of 0.73 and 0.67, respectively. Polymers 7 and 8 were only slightly active (II va: 0.31 and 0.33 for 7 and 8, respectively). Surprisingly, cosalane inhibited by only 20% (II va: 0.20) the adsorption of concentrated virus to the MT-4 cells.
The ATA analogues were also evaluated for their inhibitory effects on the binding of recombinant gp120 (rgp120) to CD4+ cells in comparison with ATA and DS. Figure 1 depicts the results of the flow cytometric analysis for ATA, DS, cosatans and polymer 7. This assay mimics HIV gp120 interaction with the CD4 receptor and is a aATA, ATA analogues, andcosalane were tested as their ammonium salts.
bTheinhibitory index of binding of HIV-1 particles (live) or rgp 120 (IIrgp12o) was determined as described in Materials and Experimental Procedures, with an index ranging from o(no inhibition of binding) to 1 (complete inhibition of binding). All compounds were evaluated at a concentration of 251lg mr", "The 50% effective concentration, or concentration required to reduce rgp120 binding to MT-4 cells by 50%. All data represent mean values for at least two separate experiments. The fluorescence 01the MT-4 cells not exposed to HIV-1 rgp120 is presented by the first histogram (cell control, CC) and the fluorescence of the MT-4 cells exposed to HIV-1 rgp120 in the absence of any compound is presented in the second histogram (rgp120). The tour following histograms represent the inhibitory effects of the compounds ATA, DS 5000, cosalane and polymer 7, respectively. All compounds were evaluated at a concentration 0125 fIg mr'. The mean fluorescence values are given between parentheses.
Interactions of the A TA-related polymers with the CD4 receptor
As the ATA-related polymer analogues proved inhibitory to the adsorption of HIV-1 to C04+ cells, they were further examined for their ability to inhibit the binding of OKT4A mAb to the C04 receptor of MT-4 cells. This mAb is directed at the HIV recognition domain of the C04 receptor on C04+ cells. At 25 fl9 mr', ATA and related polymers, except for 7 and 8, displayed 90% inhibition (lI cD4: 0.87-1.00) of OKT4A mAb binding to the cells (Table 5) .
At 100 fl9 mr', an II cD4 of approximately 0.76 was noted more defined model for evaluating compounds which inhibit HIV binding to its receptor. As shown in Table 4 , at 25 fl9 mr' all compounds, except for OS (IIrgp12o: 0.66), showed a very strong inhibitory effect on the binding of recombinant gp120 to MT-4 cells (IIrgp12o: 0.86'-1.00) comparable to that of ATA (IIrgp12o: 1.00). The EC so of inhibition of adsorption of rgp120 to the host cells (EC SO/r9P120) ranged from 0.37 fl9 mr" for polymer 1 to 6.28 fl9 rnl" for polymer 5, as compared to ATA (EC SO/r9p120: 1.42 fl9 rnl:") and OS (EC SO/rgp120: 6.82 fl9 mr'), These data were in line with the results observed in the virus adsorption assay, except for cosalane (with an " VB of only 0.20 and an "rgp120 of 0.86 in contrast to an ECSO/rgp12o of 2.09 fl9 mr') and correlated (r = 0.998) with the EC so values of the compounds in the HIV-1 cytopathicity assay ( Table 2) .
"ATA, ATA analogues and cosalane were tested as their ammonium salls. with polymers 7 and 8. Even if the cells had been in contact with the compounds for only 10-20 sec, a dose dependent loss of staining of the cells by OKT4A mAb was observed. As shown in Table 6 , ATA, polymers 1, 4 and cosalane were most effective with an ECSO/CD4 of as high as about 2 fl9 rnl", followed by polymers 2, 5 and 6 (ECSO/CD4: -10 fl9 ml-1). Polymers 7 and 8 were only slightly active (ECSO/CD4: -55 fl9 mr'), In contrast, OS showed no activity in this assay. Addition of 10% fetal calf serum strongly neutralised the inhibitory effect of most of the compounds. At 100 fl9 mr', polymers 2, 4, 5 and 6 effected an inhibition of only 19% to 45% (Table 5 ). Moreover, polymers 7 and 8 completely lost their inhibitory effect on OKT4A binding. In contrast, still more than 90% inhibition was noted with ATA, cosalane and polymer 1 at a concentration of 100 fl9 mr'. However, at 25 fl9 mr" the latter compounds exerted little if any inhibition of the binding of OKT4A mAb to the MT4cells (lI cD4: 0.27-0.12). 
Inhibitory effects of the ATA-related polymers on anti-gp120 mAb binding to gp120
We also examined whether the new polymers were able to directly interact with the viral glycoprotein gp120 which is involved in HIV binding to the cells and in syncytium Table 6 . Effects of related-ATA polymers on the binding of anti-gp120 mAb to HUT/Ills cells and on binding of OKT 4A mAb to MT-4 cells as detected by FACS analysis. blocking HIV infection. As shown in Table 5 , at 100 J.1g mr' and after 60 min preincubation, ATA, cosalane, polymers 1 and 5 proved the most active ( lI o KT 4 :~0.90), followed by polymers 2 and 6 (lI o KT4 : -0.85). When the compounds had been exposed to the cells for only 10-20 sec at room temperature, they were less inhibitory to the binding of OKT4 mAb than to the binding of OKT4A mAb to the C04+ cells (i.e., lI o KT 4 < II c D4 ) except for ATA and cosalane which showed more than 90% inhibition (Table  5 ). The results found in the OKT4 assay parallelled the data from the OKT4A assay, l.e., those polymers which displayed the highest II c D 4 , also exerted the highest inhibitory effect on the binding of OKT4 mAb to the host cells. The inhibitory effects of ATA, OS, cosalane and polymer 7 on (A) the binding of OKT4A mAb in the absence of fetal calf serum (FCS), (B) the binding of OKT4A mAb in the presence of 10% FCS, and (C) the binding of OKT4 mAb in the absence of FCS to MT-4 cells are visualised in Figure 2 
To explore in more detail the interaction of the new polymers with the C04 receptor, the compounds were tested for their ability to inhibit the binding of OKT4 mAb to MT-4 cells. This mAb is directed at a different epitope of the C04 receptor of C04+ cells and is not capable of "ATA, ATA analogues, and cosalane were tested as their ammonium salts. bThe 50% effective concentration, or concentration required to reduce anti-gp120 mAb binding to HUT/Ills cells by 50%. "The 50% effective concentration, or concentration required to reduce OKT4A mAb binding to MT-4 cells by 50%. All data represent mean values for at least two separate experiments. Fig. 3 . Inhibitory ellects of ATA, DS 5000, cosalane and polymer7 on the binding of anti-HIV-1 gp120 mAb (NEA 9284) to persistently HIV-1 (IIIB)infected HUT-78 cells. The fluorescence of the HIV-1 (IIIB)-infected HUT-78 cells not exposed to anti-HIV-1 gp120 mAb is presented by the first histogram (cell control, CC) and the fluorescence of the HUT-IIIB cells exposed to anti-HIV-1 gp120 mAb (NEA 9284) in the absence of any compound is presented by the second histogram (gp120). The four following histograms represent the inhibitory ellects of the compounds ATA, DS 5000, cosalane and polymer 7, respectively. All compounds were evaluated at a concentration of 25119 rnr". The mean fluorescence values are given between parentheses.
Discussion
formation. As shown in Table 6 , a marked inhibitory effect was observed even if the cells had been in contact with the compounds for only 15-20 min at room temperature. ATA, DS, polymers 1, 4 and cosalane emerged as the most active with ECso/gp120 values ranging from 1.40 fL9 mr' for DS to 3.49 fL9 rnr' for cosalane. Again, polymers 7 and 8 were the least effective with an ECso/gp120 of only 21 fL9 mr' and 16.3 fL9 mr', respectively. Figure 3 shows the inhibition of ATA, DS, cosalane and polymer 7 on the binding of anti-gp120 mAb (NEA 9284) to HUT-Ills Cells in histogram forms. methane unit by a three carbon linker (Fig. 4) , were the most potent of the substances tested, their antiviral spectrum being essentially identical to that of ATA. In contrast, polymer 3, in which the phenolic hydroxyl group or thiol group is not ortho to a carboxyl group, was devoid of any biological activity.
The synthesis and anti-HIV and anti-HCMV properties of the novel polymers are described in more detail by Cushman et al. (1995) . Here, we have demonstrated that the mechanism of anti-HCMV and anti-HIV-action of the new polymers can mainly be attributed to inhibition of the binding of HCMV and HIV particles to the host cells. For HCMV this is evident from the observation that the compounds that show anti-HCMV activity also inhibit the binding of radiolabelled virus particles to the host cells. A similar mechanism of action has also been found for the anti-HCMV activity of polyhydroxycarboxylates derived from phenolic (PDP) compounds and sulphated polymers (Neyts et al., 1992a (Neyts et al., ,1992b .
Using flow cytometric analysis, we have demonstrated that the anti-HIV activity of the ATA-related polymers is due to interference with the gp120-CD4 interaction, resulting in inhibition of virus binding to the cell surface. There was a close correlation between the anti-HIV activity of the compounds in the HIV cytopathicity assay (Table 2) , their inhibitory effect on giant cell formation (Cushman et al., 1995) and their inhibitory effect on HIV adsorption (Table 4 ). Polymers 7 and 8 were invariably the least active in the three assays.
A close correlation was also found between the anti-HIV activity of the compounds (Table 2) , the EC so values for inhibition of adsorption of HIV-1 rgp120 (Table 4 ) and the EC so values for inhibition of binding of anti-gp120 mAb to persistently infected HUT-Ills cells (Table 6) . ATA, polymers 1, 4 and cosalane were the most active in the three assays, followed by polymers 2, 5 and 6. Again, polymers 7 and 8, having n-propyl and ethyl substituents on the bridging carbon atoms, respectively, displayed the lowest EC so values in these assays. This close correlation suggests that the anti-HIV activity of ATA and related polymers can be ascribed to a direct interaction with the (positively charged) V3 loop of the HIV envelope glycoprotein gp120 and depends on the presence and number of anionic substituents on the backbone. These findings further corroborate the concept that negatively charged compounds such as polysulphates and polycarboxylates, containing a sufficiently high number of negative charges, inhibit viral replication through binding to positively charged domains of the glycoproteins of enveloped viruses (Neyts et al., 1992a (Neyts et al., , 1992b Schols et al., 1991) . The poly(hydroxy)carboxylates, but not the sulphated polymers (Schols et al., 1989a (Schols et al., , 1991 , also inhibit the binding of OKT4A mAb to the (HIV binding site of the) cellular CD4 receptor. The EC so values obtained with the l__ From the present study, it is clear that the ATA-related polymers, except for polymer 3, have a broad-spectrum antiviral activity against several enveloped viruses. They are particularly active against HHV-6, HCMV and HIV. This broadens their scope in the treatment of AIDS patients, where HCMV infections are the most frequent cause of death (Reichert et aI, 1983) and where HHV-6 seems to play an important role either as a cofactor in the progression of AIDS (Wang et al., 1994) or as an opportunistic infection (Corbellino et al., 1993) . Polymer 1, derived from 2,4-dihydroxybenzoic acid, polymer 2, derived from thiosalicylic acid, and cosalane, derived by attaching a cholestanyl fragment to a dichlorodisalicyl- ATA-related polymers in the OKT4A assay (Table 6) correlated closely with the data found (i) for anti-HIV activity (Table 2) , (ii) for inhibition of HIV adsorption (Table 4 ) and (iii) for inhibition of anti-gp120 mAb binding (Table 6 ). This clearly indicates that the anti-HIV activity of the new ATA analogues is also due to their interference with the cellular CD4 receptor. Even in the presence of 10% FCB, ATA, polymer 1 and cosalane, at a concentration of 100 f-lg rnl", effected a greater than 90% inhibition of binding of OKT4 A mAb to MT-4 cells ( Table 5 ). In contrast, all the other ATA analogues had lost most (I.e., polymers 2,4,5 and 6), or all (l.e., polymers 7 and 8) of their ability to react with the cellular CD4 receptor. These results lead to the conclusion that the anti-HIV activity of ATA is not associated with a very high degree of structural specificity. Accordingly, a variety of structural changes in the polymer are tolerated with the main effect being a slight to moderate decrease in potency. In more specific terms, except for the inactive polymer 3, the remaining compounds in the series 1-8 all fit in the anti-HIV (Ills) EC so range of 0.5 to 4.4 f-lg mr' for inhibition of viral cytopathic effect. This is only a slightly lower concentration range than the EC so of 0.3 f-lg rnr' observed for ATA itself (Table 1) . likeWise, the anti-HCMV and anti-HHV-6 activities of ATA do not appear to be structurally specific, as similar trends were observed in the antiviral activities of polymers 1-8 against those viruses. Although significant variability was seen in the HIV-1 gp120 and . CD4 binding assays, all of the polymers except polymer 3 displayed some degree of activity. The structures of ATA and the ATA analogues all contain a six-membered ring that is part of the backbone structure [the 'upper' ring in structure 1 (Fig. 4) ]. In all of the active polymers 1-2 and 4-8, this ring contains an oxygen or sulphur substituent positioned ottho relative to the carboxylic acid group. The inactive polymer 3, having the oxygen in meta to the carboxyl groups, is the only substance lacking an oxygen or sulphur ortho to the carboxylic acid group in the backbone ring.
The active polymers can be categorized into most potent (1,2 and 4), intermediate (5 and 6), and less potent (7 and 8) groups. The most potent substances, 1,2 and 4, have substituted salicyl or thiosalicyl rings branching from the backbone. This ring corresponds to the 'lower' ring in structure 1 (Fig. 4) . In the polymers 5 and 6, which are slightly less potent, the corresponding substituent is 2-furyl and vinyl, respectively. These substituents, in common with those of the most potent polymers, are conjugated with the adjacent quinone methide moiety. However, they do not contain carboxylic acid groups. The least potent polymers, 7 and 8, contain n-propyl and ethyl substituents, respectively. These substituents do not extend the conjugation of the quinone methide backbone. The difference in potency between the very similar substances 6 and 8 is instructive. The vinyl-containing polymer 6 was more potent than 8 in every assay examined except for inhibition of binding of HIV-1 rgp120 to MT-4 cells ( Table 4 , right-hand column). Taken together, the data demonstrate the importance of both the presence of carboxylic acid groups on the substituent protruding from the polymer backbone, as well as its ability to extend the conjugation of the quinone methide moiety.
Cosalane has been recently reported as an inhibitor of HIV-1 protease and integrase (Cushman et al., 1994 (Cushman et al., , 1995 . However, its primary mechanism of action clearly involves inhibition of gp120/CD4 interaction, as it is one of the most potent substances to inhibit (i) the binding of HIV-1 rgp120 to MT-4 cells (Table 4 ), (ll) the binding of anti-HIV-1 gp120 mAb to persistently infected HUT-Ills cells (Table 6 ) and, most importantly, (iii) the binding of OKT4A mAb and OKT4 mAb to CD4+ cells even in the presence of 10% FCS (Tables 5 and 6 ). These results indicate, for the first time, that the inhibition of gp120/CD4 binding by cosalane is due to its binding to both gp120 and CD4.
In conclusion, the new ATA polymers inhibit the replication of a variety of enveloped DNA and RNA viruses. They inhibit the first step of the replicative cycle, l.e., virus adsorption to the host cells, due to a direct interaction with the viral envelope glycoproteins as shown for herpesviruses, such as HCMV. For HIV, we could demonstrate, by using mAbs to gp120 and to CD4, that the ATA polymers interact with both gp120 and CD4. The anti-HIV activity of the ATA polymers is not associated with a high degree of structural specificity. While these polymers can be considered as new markers for probing the gp120/CD4 interaction, they may also be considered as new leads in the design of efficient inhibitors of HIV.
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Materials and Experimental Procedures
Compounds
Aurintricarboxylic acid (ATA) was obtained from Aldrich Chemical Co. (Brussels, Belgium). Dextran sulphate (OS) (MW 5000) was from SigmaChemical Co. (St. louis, MO, USA). The synthesis, analytical data, functional group analysis, molecular weight determination and characterization of the new ATA polymer analogues (including cosalane) have been described elsewhere (Cushman et et., 1994 (Cushman et et., , 1995 . For biological testing, the carboxylic acids were converted to their ammonium salts. The structures of OS(11), ATA (10),its related polymeranalogues (1-8) and cosalane (9) are represented in Fig. 4 . As with ATA (10), these new polymer analogues (1-8) were obtained as heterogeneous mixtures andthe structures in Fig.4 shouldtherefore be considered as schematic representations. In contrast, cosalane (9) is the only substance that is structurally defined.
Cells
MT-4 cells (Miyoshi et a/., 1982) , MOLT-4 cells (clone 8) (Kikukawa et a/., 1986) , HSB-2 cells (ATCC No. CCl 120.1) and persistently HIV-infected HUT-78 cells were maintained in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum (FCS), 2mM l-glutamine, 0.1% sodium bicarbonate and 20~g mr" gentamicin. Vero, EsSM and Hela cell cultures were grown in Eagle's minimum essential medium (MEM) supplemented with 10% FCS, 2mM l-glutamine and 0.1% sodiumbicarbonate. HEl (humanembryonic lung)fibroblasts were kept in MEM supplemented with 10% FCS, 2mM lglutamineand 0.02% sodium bicarbonate.
Viruses
The virus stocks were prepared as described previously: human immunodeficiency virus type 1 (HIV-1) (HTlV-III B strain) (Popovic et a/., 1984) 
Antiviral activity assays
For HSV, VV, VSV, Coxsackie, polio, parainfluenza, Sindbis, Semliki Forest, Junin, Tacaribe and reovirus, the assay pro-cedures have been described elsewhere (De Clercq et al., 1975 , 1980 Andrei and De Clercq, 1990). Briefly, confluent (Vero, HeLa or E 6SM) cell cultures in 96-well microtitre trays were exposed to 100 CCID 50 (1 CCID 50 being the infective dose for 50% of the cell cultures) of virus per well in the presence of varying concentrations of the test compounds diluted in Eagle's minimum essential medium (MEM) supplemented with 3% FCS, 2mM L-glutamine and 0.1% sodium bicarbonate. The cells were further incubated at 37"C until virus-induced cytopathic effect was completed in the control (i.e. virus-infected, untreated) cell cultures. Virus-induced cytopathicity was recorded at 1 or 2 days post infection (p.i.) for VSV; at 2 days for Coxsackie virus, Semliki Forest virus and poliovirus; at 2 to 3 days for HSV-1 (KOS), HSV-2 (G), TK-HSV-1 (VMW-1837 and B2006), VV and Sindbis virus; at 4 to 5 days for parainfluenza virus; at 5 days for Junin virus, Tacaribe virus, reovirus and Punta Toro virus and at 7-8 days for yellow fever virus.
For the anti-HCMV assays, human embryonic lung (HEL) fibroblasts in microtitre trays were infected with 100 p.f.u. (plaque forming units) per well in the presence of varying concentrations of the test compounds. Virus-induced plaque formation was evaluated 7 days p.i, .
The inhibitory effect of the test compounds on HIV-1 replication was monitored by the inhibition of virus-induced cythopathic effect in MT-4 cells. Briefly, MT-4 cells were suspended at 3 x 10 5 cells mr" and infected with HIV-1 at 100 CCID 50 ror"
in the presence of various concentrations of the test compounds. After 5 days incubation at 37"C, the number of viable cells was determined by the MTT method as previously described (Pauwels et al., 1988) .
Evaluation of the anti-HHV-6 activity was performed as described previously . Therefore, HSB-2 cells were infected with HHV-6 (GS strain) at a MOl of 0.001. Immediately after infection, 100 III of the infected cell suspension was brought into each well of a 96-well microtitre plate containing various concentrations of the test compounds. After 10 days, the inhibitory effect of the compounds on HHV-6 replication was monitored by microscopical evaluation of the virusinduced cythopathicity and viral antigen-expression was analysed by an indirect immunofluorescence/flow cytometric assay (FACS analysis).
All activities of the compounds are expressed as EC 50 l.e., the concentration required to inhibit virus-induced cythopathicity by 50%.
Cytotoxicity assays
Cytotoxicity on HSB-2 cells was evaluated as described elsewhere (Reymen et el., 1995) and expressed as CC 50 or concentration to reduce cell growth by 50%. The inhibitory effect on MT-4 cell viability (CC 50) was determined by means of the MTT method as described previously (Pauwels et al., 1988) .
Alternatively, the minimal concentration required to cause a microscopically detectable alteration of the morphology of confluent cells (minimal cytotoxic concentration or MCG) was determined.
Binding of radio/abe/ed HCMV to HEL cells
[Methyl-3HldThd-labeled HCMV was prepared as described previously (Neyts et al., 1992a) . Confluent HEL cell cultures were treated with the test compounds for 1 to 5 min at room temperature. Radiolabelled virus suspension was added to the cell cultures for an additional 30 to 60 min at 37"C. Then, the cell suspensions were lysed and radioactivity was determined in a toluene-based scintillant.
Recombinant H/V-1 gp 120 adsorption assay
The Inhibitory effects of the test compounds on binding of recombinant HIV-1 gp120 (rgp120) were determined by an indirect immunofluorescence / flow cytometric method modified from Schols et al. (1989b) . Briefly, MT-4 cells were exposed to rgp120 (1.5119 rnr': Intracel, London, UK) in the presence or absence of the test compounds. The cells were incubated for 30-40 min at 37"C and washed twice with phosphate-buffered saline (PBS) to remove unbound rgp120. Then a specific anti-HIV-1gp120 mAb (NEA 9284; DuPont de Nemours, Brussels, Belgium) was added to detect rgp120 attached to the cells. After a 50 min incubation period at 37"C, the cells were washed and incubated with f1uorescein-isothiocyanate (FITC)-Iabeled F(ab'h fragments of rabbit anti-mouse immunoglobulin antibody [RaM-lgG-F(ab'h-FITCl (Prosan, Ghent, Belgium) for another 50 min at 37"C. The cells were then washed once, fixed in 0.5 ml of 0.5% paraformaldehyde in PBS, and analysed by laser flow cytofluorography. The inhibitory index for rgp120 adsorption to MT-4 cells (IIrgp120) was calculated according to the following formula: "rgp120 = 1-[(MFrgp1200-MF00) / (MFrgp120-MFo)], whereby MFrgp1200 is the mean fluorescence (MF) for HIV-1 rgp120-inoculated cells exposed to a given concentration of the compound; MF oo is the mean fluorescence for the control cells (not exposed to rgp120) treated with compound; MFrgp120 is the mean fluorescence for rgp120 inoculated cells (not treated with any compound) and MF o is the mean fluorescence for the control cells (not exposed to rgp120 and not treated with any compound). If "rgp120= 1, there is total inhibition of HIV-1 rgp120 adsorption; if IIrgp120 = 0, there is no inhibition of HIV-1 rgp120 adsorption to the cells.
H/V-1 adsorption assay
The inhibitory effects of the test compounds on HIV-1 adsorption were measured by an indirect immunofluorescence / laser flow cytofluorographic method specifically designed for this purpose. Briefly, MT-4 cells were exposed to HIV-1 virions, which had been concentrated from the supernatant of HTLV-Ills-infected cells, in the presence or absence of the test compounds. The compounds were added 10 to 20 sec before virus was added. The cells were incubated for 30 min at 37°C, and processed for indirect immunofluorescence using a high-titre polyclonal antiserum to HIV-1 and secondary FITC-conjugated F(ab'h fragments of rabbit anti-human immunoglobulin antibody (Prosan, Ghent, Belgium). The cells where then analysed for cell-bound HIV-1 virions by laser flow cytofluorography as described by Schols et al. (1989b) .
CD4 immunofluorescence assay
The modulation of CD4 expression was investigated as previously described by Schols et al. (1989a) . Therefore, MT-4 cells were incubated for 30 sec with or without the test compounds and directly stained for immunofluorescence with either FITC-labeled OKT4A mAb (an HIV-blocking mAb directed at the gp120-fusion region, which is located in the first immunoglobulin-like domain of the CD4 receptor) or FITC-Iabeled OKT4 mAb (a non HIV-blocking mAb, directed at a proximal epitope near the transmembrane region of the CD4 molecule) (Sattentau et al., 1986; Jameson et al., 1988; Mizukami et al., 1988) . Both mAbs were purchased from Ortho Diagnostics (Beerse, Belgium). Analysis of the effect on binding of other cell surface markers was performed in a similar way, except that the cells were preincubated for 60 min (at 4°C) with the compounds.
Glycoprotein gp120 immunofluorescence assay
The interaction of the test compounds on the binding of a specific anti-gp120 mAb (directed to the V3-loop of HIV-1 gp120) (NEA 9284; DuPont de Nemours, Brussels, Belgium) to persistently HTLV-lIl s-infected-HUT-78 cells was measured by indirect immunofluorescence / flow cytometric analysis as described previously (Schols et al., 1990) . Briefly, HIV-1infected-HUT-78 cells were incubated with or without the test compounds for 15-20 min at room temperature, stained with anti-gp120 mAb (NEA 9284) and FITC-conjugated F(ab'b fragments of rabbit anti-mouse immunoglobulin antibody (Prosan, Ghent, Belgium), and analysed by flow cytometry.
